News

THE thrills and spills of the summer transfer window are well underway with some huge deals in the pipeline over the next few ...
First doctors in UK to graduate through part-time study celebrate - The group studied at the University of Edinburgh.
Universities use their endowments to fund critical operations and to provide services, such as tuition assistance to ...
A Loughborough University student has developed a new medical device that could transform how prostate health is assessed and ...
The University of Birmingham has announced the winners of the 2025 Founders’ Awards for Excellence, including a unique ...
A contagious new COVID-19 variant called NB.1.8.1, aka "Nimbus," is now dominant in the United States, CDC data show. What to know about symptoms and vaccines.
Researchers have been able to see what happens in inflamed joints of children with arthritis, giving insight into why treatments affect children differently.
Shionogi will pay BioVersys $6.3 million for developing BV500, BioVersys's drug candidate for non-tuberculous mycobacteria.
Devansh turned ambition into success with focused prep and expert guidance from GuideMe ...
Rising one place to number one overall, the British drugmaker has overtaken the NHS as the preferred destination for science ...
The Christie NHS Foundation Trust together with the Cancer Research UK National Biomarker Centre and The University of ...
EXCLUSIVE: Skin cancers can be among the most aggressive forms of the disease so using drugs to shrink them must be used with precision.